Zhejiang Langhua Pharmaceutical

Linhai, Zhejiang, China
Hybrid — also manufactures internal programs
Small Molecule API Intermediates Finished Dosage Forms Peptides
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Zhejiang Langhua Pharmaceutical

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Linhai, Zhejiang, China
Website
Modalities
Small Molecule API, Intermediates, Finished Dosage Forms, Peptides
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Zhejiang Langhua Pharmaceutical

Zhejiang Langhua Pharmaceutical makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Finished Dosage Forms, Peptides. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.langhuapharma.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Frequently Asked Questions About Zhejiang Langhua Pharmaceutical

Does Zhejiang Langhua Pharmaceutical have a CDMO Signal Score?
Not yet. Zhejiang Langhua Pharmaceutical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Zhejiang Langhua Pharmaceutical for a manufacturing program?
Use the free AI matchmaker to compare Zhejiang Langhua Pharmaceutical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Zhejiang Ausun Pharmaceutical
Taizhou, Zhejiang, China
Small Molecule API, Intermediates, Peptides, Finished Dosage Forms
ChemExpress
Shanghai, China
Small Molecule API, Intermediates, High-Potency APIs, ADC / Bioconjugation, Peptides, Oligonucleotide
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides
Fukuzyu Pharmaceutical
Toyama, Japan
Small Molecule API, Intermediates, Clinical Trial Manufacturing, Peptides, Custom Synthesis, Particle Engineering
Nissan Chemical
Sanyo-Onoda, Yamaguchi, Japan
Small Molecule API, Intermediates, High-Potency APIs, Peptides

Compare Zhejiang Langhua Pharmaceutical with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Zhejiang Langhua Pharmaceutical
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.